Maricann Group Inc. Receives Export Permit From Health Canada

World News: . []

TORONTO, April 16, 2018 (GLOBE NEWSWIRE) -- Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCMKTS:MRRCF)  (“Maricann” or “the Company”), is pleased to announce that on Friday April13, 2018, its wholly owned subsidiary, Maricann Inc. received an export permit from Health Canada for a shipment of dried cannabis flower to Germany. This is the first export permit that Maricann has received.

Ben Ward, CEO Stated, “This export permit marks another milestone in the Company’s history and an important first, as we continue to build our Company, globally. Our team of regulatory experts, led by VP of Regulatory Affairs, Dr. Alexandre Sibilev in Canada, continues to add value for Maricann shareholders through this and previous successes, demonstrating a solid track record in moving through regulatory processes. Our team has expert insight, understanding, and expertise in maintaining our existing licenses, whilst progressing in new geographies with their track record of applied expertise. Export of cannabis from Canada is an important pillar of our near-term strategy, combined with eventual in country production in new geographies, where and when permitted.”

The Company is established in Germany, with operations for its two 95% owned subsidiaries, Maricann GmbH (THC cannabis) and Mariplant GmbH (non-THC cannabis) centred at its campus in Ebersbach, Germany (between Leipzig and Dresden).  The Company is represented in both Maricann and Mariplant by full time established professionals in the pharmaceutical production and agricultural sectors, respectively.

Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario, Canada where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada, and Dresden, Saxony, Germany. Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) build out, with a designed expected capacity of producing 95,000 kg (based on conservative estimates) of dry cannabis flower per year to support existing and future patient growth.

For more information about Maricann, please visit our website at 

Investor Relations Graham Farrell Director of Investor Relations 647-643-7665 Corporate Headquarters (Canada) Maricann Group Inc. (Toronto) 845 Harrington Court, Unit 3 Burlington Ontario L7N 3P3 Canada 289-288-6274

More news and information about Maricann Group Inc.

Published By:

Globe Newswire: 13:48 GMT Monday 16th April 2018

Published: .

Search for other references to "maricann" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers